Key result
Ginsenoside Rg3 combined with chemotherapy significantly inhibited tumor growth in mice with esophageal squamous cell carcinoma, achieving a 70.64% inhibitory rate compared to 59.67% with chemotherapy alone.
Why the study?
Does ginsenoside Rg3 combined with chemotherapy improve tumor inhibition in a mouse model of esophageal squamous cell carcinoma?
Does ginsenoside Rg3 combined with chemotherapy improve tumor inhibition in a mouse model of esophageal squamous cell carcinoma?
Ginsenoside Rg3 significantly enhances the antitumor efficacy of paclitaxel and cisplatin in a mouse model of esophageal squamous cell carcinoma by reducing tumor proliferation and microvascular density.
Answers are grounded in this paper and cite their sources.
Should not yet alter clinical practice; leaves open translation of ginsenoside Rg3 adjunctive effects to human esophageal cancer trials.
The present study was conducted in order to investigate the inhibitory effects of ginsenoside Rg3 combined with chemotherapy on Eca‑109 esophageal squamous cell carcinoma (ESCC) in mice. Tumor xenograft models were established in the right forelimb of 20 BALB/c nude mice by subcutaneous injection. The tumor‑bearing mice were randomly assigned to 4 treatment groups (n=5 per group) as follows: the control group (saline), the ginsenoside Rg3 alone group (6 mg/kg/day, once a day for 3 weeks), the chemotherapy alone group (paclitaxel 10 mg/kg/day + cisplatin 5 mg/kg/day on days 1, 7, 14 and 21) and the chemotherapy + Rg3 group (combined treatment). The length and width of the tumor were directly measured with calipers at different time points and the tumor volume (cm3) was calculated using the formula 0.52 x length x width2 every other day. The mice were sacrificed by cervical dislocation following completion of therapy, the tumors were removed and weighed and the expression levels of Ki‑67 were determined by immunohistochemistry. The results indicated that the coadministration of ginsenoside Rg3 significantly enhanced the inhibitory effects of chemotherapy on tumor growth. In addition, the expression levels of Ki‑67 in the chemotherapy + Rg3 group were significantly lower compared to those in the other 3 groups. The chemotherapy + Rg3 group also exhibited the lowest microvascular density among all four groups. These findings suggested that ginsenoside Rg3 may improve the antitumor efficacy of chemotherapy in Eca‑109 ESCC in mice.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2014) studied Esophageal squamous cell carcinoma (ESCC) (n=20). Ginsenoside Rg3 combined with chemotherapy vs. Saline control, Rg3 alone, and chemotherapy alone was evaluated on Tumor volume (cm3) at day 21 (p=<0.0001). Ginsenoside Rg3 combined with chemotherapy significantly inhibited tumor growth in mice with esophageal squamous cell carcinoma, achieving a 70.64% inhibitory rate compared to 59.67% with chemotherapy alone.
Synapse has enriched 10 related papers. Consider them for comparative context: